In utero PCP exposure alters oligodendrocyte differentiation and myelination in developing rat frontal cortex

Josette S. Lindahl, Barton R. Kjellsen, Jamie Tigert, Robin Miskimins

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Several neurodevelopmental disorders, including schizophrenia, autism, ADD/ADHD and dyslexia are believed to originate during gestation and involve white matter abnormalities. Modulation of glutamate environments and glutamate receptors has also been implicated in alteration of oligodendrocytes, the myelin forming cells of the CNS. To begin to understand how modulation of the glutamate system affects the maturation of oligodendrocytes, developing rats were subjected to prenatal blockade of the NMDA receptor with phencyclidine (PCP). Oligodendrocyte development and differentiation were then examined postnatally by measuring markers for early, middle and late stage cells. The results indicate that, while the level of marker proteins for neurons and astrocytes remains the same, early oligodendrocyte progenitor cell markers are decreased in rat brains prenatally exposed to PCP. Labeling of cells of intermediate, immature cell stages is elevated. Late stage markers for myelinating oligodendrocytes are subsequently decreased. These data suggest that prenatal NMDA receptor blockade reduces the level of progenitors and that the surviving cells are arrested at an immature stage. This premature arrest appears to result in fewer fully differentiated, mature oligodendrocytes that are capable of producing myelin. These results have interesting implications for the role of glutamate and glutamate receptors in white matter abnormalities in neurodevelopmental disorders.

Original languageEnglish (US)
Pages (from-to)137-147
Number of pages11
JournalBrain Research
Volume1234
DOIs
StatePublished - Oct 9 2008

Fingerprint

Oligodendroglia
Frontal Lobe
Glutamic Acid
Glutamate Receptors
Myelin Sheath
N-Methyl-D-Aspartate Receptors
Stem Cells
Phencyclidine
Dyslexia
Autistic Disorder
Astrocytes
Schizophrenia
Neurons
Pregnancy
Brain
Proteins

Keywords

  • Glutamate excitotoxicity
  • Myelination
  • NMDA receptor
  • Neurodevelopment

ASJC Scopus subject areas

  • Neuroscience(all)
  • Molecular Biology
  • Developmental Biology
  • Clinical Neurology

Cite this

In utero PCP exposure alters oligodendrocyte differentiation and myelination in developing rat frontal cortex. / Lindahl, Josette S.; Kjellsen, Barton R.; Tigert, Jamie; Miskimins, Robin.

In: Brain Research, Vol. 1234, 09.10.2008, p. 137-147.

Research output: Contribution to journalArticle

Lindahl, Josette S. ; Kjellsen, Barton R. ; Tigert, Jamie ; Miskimins, Robin. / In utero PCP exposure alters oligodendrocyte differentiation and myelination in developing rat frontal cortex. In: Brain Research. 2008 ; Vol. 1234. pp. 137-147.
@article{5be2531ee56340bea68f38e721fda8f8,
title = "In utero PCP exposure alters oligodendrocyte differentiation and myelination in developing rat frontal cortex",
abstract = "Several neurodevelopmental disorders, including schizophrenia, autism, ADD/ADHD and dyslexia are believed to originate during gestation and involve white matter abnormalities. Modulation of glutamate environments and glutamate receptors has also been implicated in alteration of oligodendrocytes, the myelin forming cells of the CNS. To begin to understand how modulation of the glutamate system affects the maturation of oligodendrocytes, developing rats were subjected to prenatal blockade of the NMDA receptor with phencyclidine (PCP). Oligodendrocyte development and differentiation were then examined postnatally by measuring markers for early, middle and late stage cells. The results indicate that, while the level of marker proteins for neurons and astrocytes remains the same, early oligodendrocyte progenitor cell markers are decreased in rat brains prenatally exposed to PCP. Labeling of cells of intermediate, immature cell stages is elevated. Late stage markers for myelinating oligodendrocytes are subsequently decreased. These data suggest that prenatal NMDA receptor blockade reduces the level of progenitors and that the surviving cells are arrested at an immature stage. This premature arrest appears to result in fewer fully differentiated, mature oligodendrocytes that are capable of producing myelin. These results have interesting implications for the role of glutamate and glutamate receptors in white matter abnormalities in neurodevelopmental disorders.",
keywords = "Glutamate excitotoxicity, Myelination, NMDA receptor, Neurodevelopment",
author = "Lindahl, {Josette S.} and Kjellsen, {Barton R.} and Jamie Tigert and Robin Miskimins",
year = "2008",
month = "10",
day = "9",
doi = "10.1016/j.brainres.2008.06.126",
language = "English (US)",
volume = "1234",
pages = "137--147",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",

}

TY - JOUR

T1 - In utero PCP exposure alters oligodendrocyte differentiation and myelination in developing rat frontal cortex

AU - Lindahl, Josette S.

AU - Kjellsen, Barton R.

AU - Tigert, Jamie

AU - Miskimins, Robin

PY - 2008/10/9

Y1 - 2008/10/9

N2 - Several neurodevelopmental disorders, including schizophrenia, autism, ADD/ADHD and dyslexia are believed to originate during gestation and involve white matter abnormalities. Modulation of glutamate environments and glutamate receptors has also been implicated in alteration of oligodendrocytes, the myelin forming cells of the CNS. To begin to understand how modulation of the glutamate system affects the maturation of oligodendrocytes, developing rats were subjected to prenatal blockade of the NMDA receptor with phencyclidine (PCP). Oligodendrocyte development and differentiation were then examined postnatally by measuring markers for early, middle and late stage cells. The results indicate that, while the level of marker proteins for neurons and astrocytes remains the same, early oligodendrocyte progenitor cell markers are decreased in rat brains prenatally exposed to PCP. Labeling of cells of intermediate, immature cell stages is elevated. Late stage markers for myelinating oligodendrocytes are subsequently decreased. These data suggest that prenatal NMDA receptor blockade reduces the level of progenitors and that the surviving cells are arrested at an immature stage. This premature arrest appears to result in fewer fully differentiated, mature oligodendrocytes that are capable of producing myelin. These results have interesting implications for the role of glutamate and glutamate receptors in white matter abnormalities in neurodevelopmental disorders.

AB - Several neurodevelopmental disorders, including schizophrenia, autism, ADD/ADHD and dyslexia are believed to originate during gestation and involve white matter abnormalities. Modulation of glutamate environments and glutamate receptors has also been implicated in alteration of oligodendrocytes, the myelin forming cells of the CNS. To begin to understand how modulation of the glutamate system affects the maturation of oligodendrocytes, developing rats were subjected to prenatal blockade of the NMDA receptor with phencyclidine (PCP). Oligodendrocyte development and differentiation were then examined postnatally by measuring markers for early, middle and late stage cells. The results indicate that, while the level of marker proteins for neurons and astrocytes remains the same, early oligodendrocyte progenitor cell markers are decreased in rat brains prenatally exposed to PCP. Labeling of cells of intermediate, immature cell stages is elevated. Late stage markers for myelinating oligodendrocytes are subsequently decreased. These data suggest that prenatal NMDA receptor blockade reduces the level of progenitors and that the surviving cells are arrested at an immature stage. This premature arrest appears to result in fewer fully differentiated, mature oligodendrocytes that are capable of producing myelin. These results have interesting implications for the role of glutamate and glutamate receptors in white matter abnormalities in neurodevelopmental disorders.

KW - Glutamate excitotoxicity

KW - Myelination

KW - NMDA receptor

KW - Neurodevelopment

UR - http://www.scopus.com/inward/record.url?scp=52049125688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52049125688&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2008.06.126

DO - 10.1016/j.brainres.2008.06.126

M3 - Article

VL - 1234

SP - 137

EP - 147

JO - Brain Research

JF - Brain Research

SN - 0006-8993

ER -